ROBERT JIMENEZ: Open Payments
NPI 1083713614 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 16 payments from 3 companies in 2025. Trend: 2023 $1,225 · 2024 $1,800 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 13 | $352 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: INGREZZA, CAPLYTA, Qelbree.
Industry payments across TX — which companies pay providers there.
